Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...

Full description

Bibliographic Details
Main Authors: Chang Yang, Bai-Rong Xia, Zhao-Cong Zhang, Yong-Jian Zhang, Ge Lou, Wei-Lin Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
ovarian cancer
immunotherapy
tumor microenvironment
combination therapy
immune checkpoint inhibitors (ICI)
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.577869/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.577869/full

Similar Items